|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 39/395 | |||
| A61K 38/49 | |||
| A61P 27/02 |
| (11) | Number of the document | 2012826 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07724892.0 |
| Date of filing the European patent application | 2007-05-04 | |
| (97) | Date of publication of the European application | 2009-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2007/003967 |
| Date | 2007-05-04 |
| (87) | Number | WO 2007/128526 |
| Date | 2007-11-15 |
| (30) | Number | Date | Country code |
| 06360017 | 2006-05-04 | EP |
| (72) |
BONNEL, Sebastien, FR
SAHEL, José, FR
|
| (73) |
Fovea Pharmaceuticals,
Institut de la Vision 17 Rue Moreau, 75012 Paris,
FR
Fondation Ophthalmologique Adolphe De Rothschild, 25-29 rue Manin, 75940 Paris Cedex 19, FR |
| (54) | COMBINATION COMPRISING A VEGF INHIBITOR AND A SERINE PROTEASE FOR TREATING NEOVASCULAR DISEASES |
| COMBINATION COMPRISING A VEGF INHIBITOR AND A SERINE PROTEASE FOR TREATING NEOVASCULAR DISEASES |